- Allena Pharmaceuticals (NASDAQ:ALNA) -17% announced the purchase and sale of 7.31M common shares with institutional and accredited investors at a purchase price of $2.05 per share in a registered direct offering, for gross proceeds of $15M.
- Closing date on or about June 5, 2020.
- Net proceeds will be used for general working capital purposes.
Allena Pharmaceuticals announces $15M registered direct offering
Recommended For You
More Trending News
About ALNAQ Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ALNAQ | - | - |
| Allena Pharmaceuticals, Inc. | ||